Oscar Health, Inc.

NYSE:OSCR Voorraadrapport

Marktkapitalisatie: US$3.9b

Oscar Health Toekomstige groei

Future criteriumcontroles 4/6

Oscar Health zal naar verwachting groeien in winst en omzet met respectievelijk 68.7% en 16.1% per jaar. De winst per aandeel zal naar verwachting groeien met 64.6% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 18% zijn.

Belangrijke informatie

68.7%

Groei van de winst

64.6%

Groei van de winst per aandeel

Insurance winstgroei11.7%
Inkomstengroei16.1%
Toekomstig rendement op eigen vermogen18.0%
Dekking van analisten

Low

Laatst bijgewerkt19 Nov 2024

Recente toekomstige groei-updates

Results: Oscar Health, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

May 11
Results: Oscar Health, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Recent updates

Not Many Are Piling Into Oscar Health, Inc. (NYSE:OSCR) Stock Yet As It Plummets 27%

Oct 29
Not Many Are Piling Into Oscar Health, Inc. (NYSE:OSCR) Stock Yet As It Plummets 27%

Not Many Are Piling Into Oscar Health, Inc. (NYSE:OSCR) Just Yet

Sep 13
Not Many Are Piling Into Oscar Health, Inc. (NYSE:OSCR) Just Yet

Oscar Health: At Nearly 4x Book Value Investors Should Wait For A Pullback

Sep 03

Oscar Health: Achieves Profitability In Q1 2024, But Uncertainties Remain

Jul 02

Results: Oscar Health, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

May 11
Results: Oscar Health, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Investors Still Aren't Entirely Convinced By Oscar Health, Inc.'s (NYSE:OSCR) Revenues Despite 30% Price Jump

May 03
Investors Still Aren't Entirely Convinced By Oscar Health, Inc.'s (NYSE:OSCR) Revenues Despite 30% Price Jump

Oscar Health: Strong Industry Catalyst With Margin Expansion Potential

Apr 13

This Analyst Just Made An Upgrade To Their Oscar Health, Inc. (NYSE:OSCR) Earnings Forecasts

Feb 12
This Analyst Just Made An Upgrade To Their Oscar Health, Inc. (NYSE:OSCR) Earnings Forecasts

Oscar Health, Inc. (NYSE:OSCR) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates

Feb 10
Oscar Health, Inc. (NYSE:OSCR) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates

Oscar Health: Flexible Business Model Is Paying Off

Jan 30

Further Upside For Oscar Health, Inc. (NYSE:OSCR) Shares Could Introduce Price Risks After 37% Bounce

Jan 19
Further Upside For Oscar Health, Inc. (NYSE:OSCR) Shares Could Introduce Price Risks After 37% Bounce

Oscar Health, Inc. (NYSE:OSCR) Soars 49% But It's A Story Of Risk Vs Reward

Nov 21
Oscar Health, Inc. (NYSE:OSCR) Soars 49% But It's A Story Of Risk Vs Reward

Oscar Health: Q3 Earnings Suggest Growth Can Continue Into 2024

Nov 15

Oscar Health: Decreasing Memberships Is Worrying

Sep 22

Oscar Health Shares Quadrupled, But They Are Still Cheap

Jul 03

Oscar Health: High Growth And Improving Profitability Make It A Buy

Jun 15

Oscar Health Insurance GAAP EPS of -$1.05 beats by $0.03, revenue of $995M misses by $415M

Feb 09

Oscar Health: Wait For Concrete Evidence The Business Can Turn Profitable

Jan 18

Oscar Health Is Back On Track

Nov 11

Oscar Health: Improving Risk/Reward Profile To Watch

Oct 03

Florida health insurer terminating agreement with Oscar Health

Aug 30

Winst- en omzetgroeiprognoses

NYSE:OSCR - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/202612,2473036255685
12/31/202511,8541606123155
12/31/20249,262241,2056325
9/30/20248,21529901928N/A
6/30/20247,23218253279N/A
3/31/20246,534-54-77-53N/A
12/31/20235,861-271-298-272N/A
9/30/20235,437-347-444-418N/A
6/30/20234,982-474154183N/A
3/31/20234,482-571202232N/A
12/31/20223,989-606351380N/A
9/30/20223,519-579234263N/A
6/30/20222,983-598197223N/A
3/31/20222,491-5593863N/A
12/31/20211,894-573-208-182N/A
9/30/20211,439-571-149-127N/A
6/30/20211,096-439224243N/A
3/31/2021682-406417434N/A
12/31/2020391-414209223N/A
12/31/2019476-261-191-165N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei OSCR ( 68.7% per jaar) ligt boven de spaarquote ( 2.6% ).

Winst versus markt: De winst van OSCR ( 68.7% per jaar) zal naar verwachting sneller groeien dan de US markt ( 15.4% per jaar).

Hoge groeiwinsten: De winst van OSCR zal naar verwachting de komende 3 jaar aanzienlijk groeien.

Omzet versus markt: De omzet van OSCR ( 16.1% per jaar) zal naar verwachting sneller groeien dan de markt US ( 8.9% per jaar).

Hoge groei-inkomsten: De omzet van OSCR ( 16.1% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen OSCR zal naar verwachting over 3 jaar laag zijn ( 18 %).

Ontdek groeibedrijven

7D

1Y

7D

1Y

7D

1Y